Sulphasalazine is a potent inhibitor of prostaglandin 15-hydroxydehydrogenase: possible basis for therapeutic action in ulcerative colitis.
about
Prostanoids as friends, not foes: further evidence from the interference by cycloxygenase-inhibitory drugs when inducing tolerance to experimental arthritigens in ratsImpaired mucosal defense to acute colonic injury in mice lacking cyclooxygenase-1 or cyclooxygenase-2.Insights from advances in research of chemically induced experimental models of human inflammatory bowel disease.Analgesic ingestion and other factors preceding relapse in ulcerative colitis.Inhibition of leucocyte motility by drugs used in ulcerative colitisImbalance of prostacyclin and thromboxane synthesis in Crohn's disease.Sulphasalazine and PhCL28A inhibit the formation of ethanol- and phenylbutazone-induced rat gastric ulcers: lack of involvement of endogenous prostaglandins?Effects of sulphasalazine and its metabolites on prostaglandin synthesis, inactivation and actions on smooth muscleRelapse of ulcerative proctocolitis during treatment with non-steroidal anti-inflammatory drugs.Inflammatory intermediaries in inflammatory bowel disease.Male contraception: current status and future prospects.Effect of sulphasalazine on pulmonary inactivation of prostaglandin F2 alpha in the pig.Prostaglandins and ulcerative colitis.Are prostaglandins cytoprotective in the human large intestine? The effect of indomethacin on rectal mucosal function and prostaglandin E2 release in vivo.Rectal mucosal prostaglandin E2 release and its relation to disease activity, electrical potential difference, and treatment in ulcerative colitis.Effects of prostaglandin E2 (PGE2) and drugs affecting PGE2 degradation on acute rejection of rat cardiac allografts.
P2860
Q28193024-346BAEBB-9BB4-415A-80AA-DC2C0B918644Q33938703-03E3301C-B158-4FC7-AB0E-CFB2448848CDQ34233126-BEE3C785-65A4-485B-AAD8-2E90CFA9FC2FQ34495790-5CCED09A-9D33-4362-A1B0-03894DE5F8CDQ34496132-2C9C4577-F6C9-4E8C-ADEA-307BAF49F162Q34496305-EE051B7B-FD4A-4B6E-AEFE-E8933E707676Q35755379-79D741D9-864C-4517-96E3-0C1BE5428D71Q36096645-884D6C9B-B511-4A3B-B9C2-4C5CE11A31E6Q36714535-02B6526C-C9BE-4472-9C91-6A9FEB596469Q38660602-179DACBA-F65F-4629-9853-08D21D0370CDQ39577556-80B547AA-65BE-4D45-84A4-67FD52EA31B0Q39931852-CBAB3BFB-1898-4D4B-A382-CBACBF4291CBQ40096108-B631B6FD-3026-4BD3-9B2E-ECB993B1E6B2Q41584822-FA261CB5-A010-4C86-B9B7-FA26E9E7526EQ42136135-C35458DD-57ED-4AE5-869C-39508EC748BDQ45256907-B607D126-E8FF-4A22-AEB0-27DFCDF47D01
P2860
Sulphasalazine is a potent inhibitor of prostaglandin 15-hydroxydehydrogenase: possible basis for therapeutic action in ulcerative colitis.
description
1978 nî lūn-bûn
@nan
1978年の論文
@ja
1978年論文
@yue
1978年論文
@zh-hant
1978年論文
@zh-hk
1978年論文
@zh-mo
1978年論文
@zh-tw
1978年论文
@wuu
1978年论文
@zh
1978年论文
@zh-cn
name
Sulphasalazine is a potent inh ...... action in ulcerative colitis.
@en
Sulphasalazine is a potent inh ...... action in ulcerative colitis.
@nl
type
label
Sulphasalazine is a potent inh ...... action in ulcerative colitis.
@en
Sulphasalazine is a potent inh ...... action in ulcerative colitis.
@nl
prefLabel
Sulphasalazine is a potent inh ...... action in ulcerative colitis.
@en
Sulphasalazine is a potent inh ...... action in ulcerative colitis.
@nl
P2860
P1476
Sulphasalazine is a potent inh ...... action in ulcerative colitis.
@en
P2093
P2860
P356
10.1111/J.1476-5381.1978.TB08633.X
P407
P577
1978-09-01T00:00:00Z